Please Wait.....
Report
23 Valent Pneumococcal Polysaccharide Vaccine Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030
Market Report I 2023-12-04 I 255 Pages I Infinium Global Research and Consulting Solutions
The report on the global 23 valent pneumococcal polysaccharide vaccine market provides qualitative and quantitative analysis for the period from 2021-2030. The global 23 valent pneumococcal polysaccharide vaccine market was valued at USD 2,112.97 million in 2022 and is expected to reach USD 4,212.53 million in 2030, with a CAGR of 9.06% during the forecast period 2023-2030. The study on 23 valent pneumococcal polysaccharide vaccine market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.
The report on 23 valent pneumococcal polysaccharide vaccine market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global 23 valent pneumococcal polysaccharide vaccine market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global 23 valent pneumococcal polysaccharide vaccine market over the period of 2021-2030. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings
1) Drivers
- The 23-valent pneumococcal polysaccharide vaccine market is driven by the increasing geriatric population.
- Rising government initiatives and vaccination programs fuel the market growth.
2) Restraints
3) Opportunities
- The pricing issues make the vaccine less accessible, particularly in low-income regions can act as a barrier to the market growth.
- The continued expansion of vaccination programs, in developed and developing regions, presents a prominent opportunity for market growth.
Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
Segment Covered
The global 23 valent pneumococcal polysaccharide vaccine market is segmented on the basis of type, age group, and distribution channel.
The Global 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
- Pre-filled Syringe
- Single Dose Vial
The Global 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
- 2-10 Years
- 10-64 Years
- 64+ Years
The Global 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
- Hospitals
- Clinics
- Others
Company Profiles
The companies covered in the report include
- Merck & Co., Inc.
- GSK plc.
- Walvax Biotechnology Co., Ltd.
- Zhi Fei Biological
- SINOVAC
- Chengdu Institute of Biology (CIB)
- Sanofi
- Pfizer Inc.
- Beijing Minhai Biological Technology Co., Ltd.
- Serum Institute of India Pvt. Ltd.
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the 23 valent pneumococcal polysaccharide vaccine market.
2. Complete coverage of all the segments in the 23 valent pneumococcal polysaccharide vaccine market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global 23 valent pneumococcal polysaccharide vaccine market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. 23 Valent Pneumococcal Polysaccharide Vaccine Market Highlights
2.2. 23 Valent Pneumococcal Polysaccharide Vaccine Market Projection
2.3. 23 Valent Pneumococcal Polysaccharide Vaccine Market Regional Highlights
Chapter 3. Global 23 Valent Pneumococcal Polysaccharide Vaccine Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Type
3.4.2. IGR-Growth Matrix Analysis by Age Group
3.4.3. IGR-Growth Matrix Analysis by Distribution Channel
3.4.4. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of 23 Valent Pneumococcal Polysaccharide Vaccine Market
Chapter 4. 23 Valent Pneumococcal Polysaccharide Vaccine Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global 23 Valent Pneumococcal Polysaccharide Vaccine Market
5.2. Companies Profiles
5.2.1. Merck & Co., Inc.
5.2.2. GSK plc.
5.2.3. Walvax Biotechnology Co., Ltd.
5.2.4. Zhi Fei Biological
5.2.5. SINOVAC
5.2.6. Chengdu Institute of Biology (CIB)
5.2.7. Sanofi
5.2.8. Pfizer Inc.
5.2.9. Beijing Minhai Biological Technology Co., Ltd.
5.2.10. Serum Institute of India Pvt. Ltd.
Chapter 6. Global 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
6.1. Pre-filled Syringe
6.2. Single Dose Vial
Chapter 7. Global 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
7.1. 2-10 Years
7.2. 10-64 Years
7.3. 64+ Years
Chapter 8. Global 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
8.1. Hospitals
8.2. Clinics
8.3. Others
Chapter 9. Global 23 Valent Pneumococcal Polysaccharide Vaccine Market by Region 2023-2030
9.1. North America
9.1.1. North America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.1.2. North America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.1.3. North America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.1.4. North America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Country
9.1.4.1. The U.S. 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.1.4.1.1. The U.S. 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.1.4.1.2. The U.S. 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.1.4.1.3. The U.S. 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.1.4.2. Canada 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.1.4.2.1. Canada 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.1.4.2.2. Canada 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.1.4.2.3. Canada 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.1.4.3. Mexico 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.1.4.3.1. Mexico 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.1.4.3.2. Mexico 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.1.4.3.3. Mexico 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.2. Europe
9.2.1. Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.2.2. Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.2.3. Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.2.4. Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Country
9.2.4.1. Germany 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.2.4.1.1. Germany 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.2.4.1.2. Germany 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.2.4.1.3. Germany 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.2.4.2. United Kingdom 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.2.4.2.1. United Kingdom 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.2.4.2.2. United Kingdom 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.2.4.2.3. United Kingdom 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.2.4.3. France 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.2.4.3.1. France 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.2.4.3.2. France 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.2.4.3.3. France 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.2.4.4. Italy 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.2.4.4.1. Italy 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.2.4.4.2. Italy 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.2.4.4.3. Italy 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.2.4.5. Rest of Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.2.4.5.1. Rest of Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.2.4.5.2. Rest of Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.2.4.5.3. Rest of Europe 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.3. Asia Pacific
9.3.1. Asia Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.3.2. Asia Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.3.3. Asia Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.3.4. Asia Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Country
9.3.4.1. China 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.3.4.1.1. China 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.3.4.1.2. China 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.3.4.1.3. China 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.3.4.2. Japan 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.3.4.2.1. Japan 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.3.4.2.2. Japan 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.3.4.2.3. Japan 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.3.4.3. India 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.3.4.3.1. India 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.3.4.3.2. India 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.3.4.3.3. India 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.3.4.4. South Korea 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.3.4.4.1. South Korea 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.3.4.4.2. South Korea 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.3.4.4.3. South Korea 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.3.4.5. Australia 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.3.4.5.1. Australia 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.3.4.5.2. Australia 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.3.4.5.3. Australia 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.3.4.6. Rest of Asia-Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.3.4.6.1. Rest of Asia-Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.3.4.6.2. Rest of Asia-Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.3.4.6.3. Rest of Asia-Pacific 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.4. RoW
9.4.1. RoW 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.4.2. RoW 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.4.3. RoW 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.4.4. RoW 23 Valent Pneumococcal Polysaccharide Vaccine Market by Sub-region
9.4.4.1. Latin America 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.4.4.1.1. Latin America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.4.4.1.2. Latin America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.4.4.1.3. Latin America 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.4.4.2. Middle East 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.4.4.2.1. Middle East 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.4.4.2.2. Middle East 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.4.4.2.3. Middle East 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
9.4.4.3. Africa 23 Valent Pneumococcal Polysaccharide Vaccine Market
9.4.4.3.1. Africa 23 Valent Pneumococcal Polysaccharide Vaccine Market by Type
9.4.4.3.2. Africa 23 Valent Pneumococcal Polysaccharide Vaccine Market by Age Group
9.4.4.3.3. Africa 23 Valent Pneumococcal Polysaccharide Vaccine Market by Distribution Channel
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security